Predictors and trajectories of fear of cancer recurrence in Chinese breast cancer patients

被引:8
|
作者
Yang, Yuan [1 ]
Qi, Han [2 ,3 ,4 ]
Li, Wengao [5 ]
Liu, Ting [6 ]
Xu, Wenjing [7 ,8 ]
Zhao, Shunzhen [8 ]
Yang, Fan [1 ]
Humphris, Gerry [9 ]
Chen, Yu [10 ]
Sun, Hengwen [8 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Mental Hlth Ctr, Guangzhou 510080, Peoples R China
[2] Capital Med Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100000, Peoples R China
[3] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing 100000, Peoples R China
[4] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100000, Peoples R China
[5] Guangdong 999 Brain Hosp, Dept Psychiat, Guangzhou 510515, Peoples R China
[6] Southern Med Univ, Naang Hosp, Dept Psychiat, Guangzhou 510515, Peoples R China
[7] Southern Med Univ, Sch Clin Med 2, Guangzhou 510515, Peoples R China
[8] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Canc Ctr, Guangzhou 510080, Peoples R China
[9] Univ St Andrews, Med Sch, Div Populat & Behav Sci, St Andrews KY16 9TF, Scotland
[10] Southern Med Univ, Sch Nursing, Guangzhou 510515, Peoples R China
关键词
Breast cancer; Fear of cancer recurrence; Longitudinal; Predictors; Trajectory; PSYCHOLOGICAL DISTRESS; YOUNG-WOMEN; ANXIETY; HISTORY; PROGRESSION; PREVALENCE; SURVIVORS; SYMPTOMS; ADULT; AGE;
D O I
10.1016/j.jpsychores.2023.111177
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Fear of cancer recurrence (FCR) is one of the most common and aversive psychological phenomena among cancer patients. This study explored the trajectories of FCR over the 18 months following discharge, and evaluated the associations between baseline demographic and clinical variables and FCR trajectories among Chinese women treated for breast cancer. Methods: This is a longitudinal prospective study. All participants were asked to completed a battery of ques-tionnaires (FCR-7, PHQ-9, GAD-7 and MPQ-VAS) at baseline, 6, 12, and 18 months after discharge. Generalized linear mixed model and group-based trajectory analyses were conducted.Results: Three hundred women with breast cancer were recruited. Latent class growth modeling analysis showed that three-group trajectory solution was the best fitting (i.e., 'intermediate level-stable group' (63.3%), 'low level-increasing group' (18.3%), and 'high level-decreasing group' (18.3%). Patients reported significant higher FCR at baseline assessment compared to other time points. Significant positive associations were found between anxiety, depression and FCR. Patients who had no baseline depression (estimate =-2.14, 95% CI: - 2.78- (-1.51), P < 0.001) or anxiety (estimate =-2.77, 95% CI:-3.44-(-2.10), P < 0.001) tended to report sig-nificant lower FCRs over time. Women with none/mild life stress exhibited significant lower FCRs than those with moderate/high life stress, and participants with a family history of cancer or pessimism reported higher FCRs. Conclusion: >60% of the breast cancer women showed intermediate level-stable FCRs over the 18 months after discharge. Baseline anxiety, depression, life stress, family cancer history and pessimism predicts higher FCR levels. Clinical teams responsible for continuing patient care following treatment should develop clearer stra-tegies for management of FCR.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Predictors of recurrence in breast cancer patients with pathological partial response
    Trabulus, Fadime Didem Can
    Nazli, Mehmet Ali
    Arslan, Esra
    Mermut, Ozlem
    Dal, Fatih
    Akce, Bulent
    Gursu, Riza Umar
    Talu, Esra Canan Kelten
    Couteau, Jacqueline Nur Adira
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (03):
  • [32] Fear of cancer recurrence and coping attitudes of breast cancer survivors
    Oztas, Bediye
    Ugurlu, Meltem
    Kurt, Gonul
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [33] Selective Attention and Fear of Cancer Recurrence in Breast Cancer Survivors
    Custers, J. A. E.
    Becker, E. S.
    Gielissen, M. F. M.
    Van Laarhoven, H. W. M.
    Rinck, M.
    Prins, J. B.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2015, 49 (01) : 66 - 73
  • [34] Psychometric Properties of the Short Form of the Fear of Cancer Recurrence Inventory (FCRI) in Chinese Breast Cancer Survivors
    Peng, Li
    Huang, Weirong
    Zhang, Wenmo
    Xu, Yuanyuan
    Lu, Fang
    Zhong, Ling
    Chen, Xianchun
    Xu, Song
    Chen, Wenjun
    Li, Min
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 10
  • [35] Fear of Recurrence After Breast Cancer Treatment
    Hauspie, Sarah
    Crombez, Geert
    [J]. PSYCHO-ONCOLOGY, 2013, 22 : 328 - 329
  • [36] Survivorship care plans and fear of recurrence in patients with breast cancer (BC).
    Weiss, Marisa C.
    Chino, Junzo P.
    Thom, Bridgette
    Meske, Sam
    Ganz, Patricia A.
    Chino, Fumiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Brief screening of patients with distressing fear of recurrence in breast cancer survivors
    Tatsuo Akechi
    Kanae Momino
    Hiroji Iwata
    [J]. Breast Cancer Research and Treatment, 2015, 153 : 475 - 476
  • [38] Brief screening of patients with distressing fear of recurrence in breast cancer survivors
    Akechi, Tatsuo
    Momino, Kanae
    Iwata, Hiroji
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (02) : 475 - 476
  • [39] Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors
    Ashing, Kimlin Tam
    Cho, Dalnim
    Lai, Lily
    Yeung, Sophia
    Young, Lucy
    Yeon, Christina
    Fong, Yuman
    [J]. PSYCHO-ONCOLOGY, 2017, 26 (12) : 2253 - 2260
  • [40] The fear of cancer recurrence and progression in patients with pancreatic cancer
    Pijnappel, Esther N.
    Dijksterhuis, Willemieke P. M.
    Sprangers, Mirjam A. G.
    Augustinus, Simone
    De Vos-Geelen, Judith
    de Hingh, Ignace H. J. T.
    Molenaar, Izaak Q.
    Busch, Olivier R.
    Besselink, Marc G.
    Wilmink, Johanna W.
    van Laarhoven, Hanneke W. M.
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 4879 - 4887